Recombinant Human Pyruvate Dehydrogenase E1-alpha subunit protein (ab125602)

製品の概要

製品の詳細

  • 由来Recombinant
  • 由来Escherichia coli
  • アミノ酸配列
    • アクセッション番号P08559
    • 生物種Human
    • 分子量47 kDa
    • 領域30 to 390
    • タグHis tag N-Terminus

特性

Our Abpromise guarantee covers the use of ab125602 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • アプリケーション

    Functional Studies

    Western blot

    SDS-PAGE

  • 精製度> 85 % Densitometry.

  • 製品の状態Liquid
  • 備考

    ab125602 (Human Pyruvate Dehydrogenase E1-alpha subunit full length protein) can be utilized as a substrate for the following active protein Kinases:

     

    ab125560 (Active human PDK4 full length protein)

    ab125580 (Active human Mitochondrial Pyruvate dehydrogenase kinase 1 full length protein)
    ab125592 (Active human PDK2 full length protein)
    ab125606 (Active human PDK3 full length protein)

     

  • Concentration information loading...

前処理および保存

  • 保存方法および安定性

    Shipped on dry ice. Upon delivery aliquot and store at -80ºC. Avoid freeze / thaw cycles.

    pH: 7.00
    Preservative: 1.02% Imidazole
    Constituents: 0.002% PMSF, 0.81% Sodium phosphate, 0.004% DTT, 25% Glycerol, 1.75% Sodium chloride

関連情報

  • 別名
    • ODPA_HUMAN
    • PDH
    • PDHA
    • PDHA1
    • PDHCE1A
    • PDHE1 A type I
    • PDHE1-A type I
    • PHE1A
    • Pyruvate Dehydrogenase (lipoamide) alpha 1
    • Pyruvate dehydrogenase complex, E1 alpha polypeptide 1
    • Pyruvate Dehydrogenase E1 alpha
    • Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial
    see all
  • 機能The pyruvate dehydrogenase complex catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2). It contains multiple copies of three enzymatic components: pyruvate dehydrogenase (E1), dihydrolipoamide acetyltransferase (E2) and lipoamide dehydrogenase (E3).
  • 組織特異性Ubiquitous.
  • 関連疾患Defects in PDHA1 are a cause of pyruvate decarboxylase E1 component deficiency (PDHE1 deficiency) [MIM:312170]. PDHE1 deficiency is the most common enzyme defect in patients with primary lactic acidosis. It is associated with variable clinical phenotypes ranging from neonatal death to prolonged survival complicated by developmental delay, seizures, ataxia, apnea, and in some cases to an X-linked form of Leigh syndrome (X-LS).
    Defects in PDHA1 are the cause of X-linked Leigh syndrome (X-LS) [MIM:308930]. X-LS is an early-onset progressive neurodegenerative disorder with a characteristic neuropathology consisting of focal, bilateral lesions in one or more areas of the central nervous system, including the brainstem, thalamus, basal ganglia, cerebellum, and spinal cord. The lesions are areas of demyelination, gliosis, necrosis, spongiosis, or capillary proliferation. Clinical symptoms depend on which areas of the central nervous system are involved. The most common underlying cause is a defect in oxidative phosphorylation. LS may be a feature of a deficiency of any of the mitochondrial respiratory chain complexes.
  • 細胞内局在Mitochondrion matrix.
  • Information by UniProt

Recombinant Human Pyruvate Dehydrogenase E1-alpha subunit protein 画像

Recombinant Human Pyruvate Dehydrogenase E1-alpha subunit protein (ab125602) 使用論文

ab125602 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab125602.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"